FBXW7 metabolic reprogramming inhibits the development of colon cancer by down-regulating the activity of arginine/mToR pathways
PLOS ONE · 2025
DOI: 10.1371/journal.pone.0317294 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2025. Verfasst von Qing Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center of Gene Sequencing, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical Univ…. Hauptthemen laut MEDLINE: F-Box-WD Repeat-Containing Protein 7, TOR Serine-Threonine Kinases, Signal Transduction, Arginine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shanxi Province Science Foundation for Youths, Science and Technology Innovation Project of Universities in Shanxi.
Abstract (Originalsprache)
FBXW7 is a tumor suppressor gene that regulates metabolism and is associated with the onset and progression of colorectal cancer (CRC)), however, the precise mechanism whereby FBXW7 participates in the metabolic reprogramming of CRC remains unclear. Here, the research aims to reveal the association between the expression of FBXW7 and clinical variables and to investigate the molecular mechanism by which FBXW7 plays a critical role in the development of CRC. The clinical importance of FBXW7 in CRC was determined by immunohistochemistry. Non-targeted metabolomics was utilized to explore the role of FBXW7 in the metabolic regulation of CRC. Low expression of FBXW7 was associated with poor prognosis in individuals with CRC, both at the mRNA and protein levels. FBXW7 over-expression inhibited CRC cell growth, colony formation, migration, and invasion. Non-targeted metabolomics unveiled that FBXW7 over-expression directly caused the deprivation of arginine which led to downmodulation of mTOR signaling pathway; meanwhile, FBXW7-related metabolites were primarily concentrated in the mTOR signaling pathway. In summary, the research identified a novel mechanism of action of FBXW7 in CRC. The research findings provide a theoretical foundation for the prognostic prediction and therapeutic planning of CRC based on metabolic reprogramming.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center of Gene Sequencing, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, P. R. China.
- Department of Epidemiology, Academy of Medical Sciences, School of Public Health, Shanxi Medical University, Taiyuan, P. R. China.
- Academy of Medical Sciences, Shanxi Medical University, Taiyuan, China.
- Endoscopic Center of Shanxi Province Cancer Hospital, Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences, Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, P. R. China.
- Department of General Surgery, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, China.
- Shanxi Jinzhong Health School, Jinzhong, P. R. China.
ORCID-Profile: Qing Li
Förderung
- National Natural Science Foundation of China
- Shanxi Province Science Foundation for Youths
- Science and Technology Innovation Project of Universities in Shanxi
- Shanxi Bethune Hospital National Natural Seed Players Cultivation Project
- Basic Research Program of Shanxi Province
Zitieren
APA
Li, Q., Li, Y., Zhou, T., Zhang, Y., Li, H., Yuan, F., & Bi, Y. (2025). FBXW7 metabolic reprogramming inhibits the development of colon cancer by down-regulating the activity of arginine/mToR pathways. PLOS ONE. https://doi.org/10.1371/journal.pone.0317294
Vancouver
Li Q, Li Y, Zhou T, Zhang Y, Li H, Yuan F, et al. FBXW7 metabolic reprogramming inhibits the development of colon cancer by down-regulating the activity of arginine/mToR pathways. PLOS ONE. 2025. doi:10.1371/journal.pone.0317294
BibTeX
@article{Li2025,
author = {Li, Qing and Li, Yan and Zhou, Tong and Zhang, Yong and Li, Huiyu and Yuan, Fajia and Bi, Yanghui},
title = {FBXW7 metabolic reprogramming inhibits the development of colon cancer by down-regulating the activity of arginine/mToR pathways},
journal = {PLOS ONE},
year = {2025},
doi = {10.1371/journal.pone.0317294}
}
EUVIMED